> top > docs > PMC:7195088 > spans > 23254-25323 > annotations

PMC:7195088 / 23254-25323 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T22 1273-1279 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T19 1273-1279 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T114 94-102 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T115 308-316 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T116 595-603 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T117 673-681 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T118 822-830 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T119 1082-1090 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T120 1374-1382 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T121 1655-1663 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T122 1942-1950 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T123 2020-2028 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T116 109-114 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T117 610-615 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T118 837-842 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T119 939-940 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T120 1156-1157 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T121 1248-1249 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T122 1389-1394 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T123 1471-1475 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T124 1957-1962 http://purl.obolibrary.org/obo/CLO_0007225 denotes label

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T275 16-27 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T276 32-43 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T277 48-59 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T278 65-76 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T279 109-114 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T280 216-227 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T281 233-244 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T282 249-260 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T283 266-285 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T284 266-275 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T285 276-285 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T286 324-343 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T287 324-333 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T288 334-343 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T289 349-360 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T290 365-374 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T291 375-384 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T292 390-401 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T293 406-417 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T294 423-442 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T295 423-432 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T296 433-442 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T297 447-456 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T298 457-466 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T299 472-483 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T300 489-500 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T301 505-514 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T302 515-524 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T303 530-541 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T304 547-558 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T305 610-615 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T306 739-757 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T307 763-772 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T308 773-783 Chemical denotes cobicistat http://purl.obolibrary.org/obo/CHEBI_72291
T309 837-842 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T310 1008-1019 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T311 1025-1036 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T312 1041-1052 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T313 1324-1335 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T314 1389-1394 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T315 1458-1470 Chemical denotes nucleic acid http://purl.obolibrary.org/obo/CHEBI_33696
T316 1466-1470 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T317 1563-1574 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T318 1580-1591 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T319 1596-1607 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T320 1613-1632 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T321 1613-1622 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T322 1623-1632 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T323 1671-1690 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T324 1671-1680 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T325 1681-1690 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T326 1696-1707 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T327 1712-1721 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T328 1722-1731 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T329 1737-1748 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T330 1753-1764 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T331 1770-1789 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T332 1770-1779 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T333 1780-1789 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T334 1794-1803 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T335 1804-1813 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T336 1819-1830 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T337 1836-1847 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T338 1852-1861 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T339 1862-1871 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T340 1877-1888 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T341 1894-1905 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T342 1957-1962 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T172 104-145 Sentence denotes Open-label RCT (NCT04310228, recruiting).
T173 146-199 Sentence denotes Primary endpoint: clinical cure (follow-up 3 months).
T174 200-604 Sentence denotes • Comparison of oseltamivir plus chloroquine vs. oseltamivir plus lopinavir/ritonavir in patients with mild COVID-19 and of lopinavir/ritonavir plus oseltamivir vs. darunavir/ritonavir plus oseltamivir vs. favipiravir plus lopinavir/ritonavir vs. darunavir/ritonavir plus oseltamivir plus chloroquine vs. darunavir/ritonavir plus favipiravir plus oseltamivir in patients with moderate to severe COVID-19.
T175 605-654 Sentence denotes Open-label RCT (NCT04303299, not yet recruiting).
T176 655-722 Sentence denotes Primary endpoint: SARS-CoV-2 eradication time (follow-up 24 weeks).
T177 723-831 Sentence denotes • Comparison of hydroxychloroquine plus darunavir/cobicistat vs. standard of care in patients with COVID-19.
T178 832-873 Sentence denotes Open-label RCT (NCT04304053, recruiting).
T179 874-991 Sentence denotes Primary endpoint: incidence of secondary cases among contacts of a case and contacts of contacts (follow-up 14 days).
T180 992-1091 Sentence denotes • Comparison of chloroquine plus favipiravir vs. favipiravir vs. placebo in patients with COVID-19.
T181 1092-1135 Sentence denotes Double-blind RCT (NCT04319900, recruiting).
T182 1136-1307 Sentence denotes Primary endpoints: (a) time to improvement/recovery and frequency of improvement/recovery (follow-up 10 days); (b) time to negative swab/sputum RT-PCR (follow-up 10 days).
T183 1308-1383 Sentence denotes • Comparison of favipiravir vs. standard of care in patients with COVID-19.
T184 1384-1433 Sentence denotes Open-label RCT (NCT04333589, not yet recruiting).
T185 1434-1546 Sentence denotes Primary endpoint: viral nucleic acid test negative conversion rate in nasopharyngeal swabs (follow-up 5 months).
T186 1547-1951 Sentence denotes • Comparison of oseltamivir plus chloroquine vs. oseltamivir plus lopinavir/ritonavir in patients with mild COVID-19 and of lopinavir/ritonavir plus oseltamivir vs. darunavir/ritonavir plus oseltamivir vs. favipiravir plus lopinavir/ritonavir vs. darunavir/ritonavir plus oseltamivir plus chloroquine vs. darunavir/ritonavir plus favipiravir plus oseltamivir in patients with moderate to severe COVID-19.
T187 1952-2001 Sentence denotes Open-label RCT (NCT04303299, not yet recruiting).
T188 2002-2069 Sentence denotes Primary endpoint: SARS-CoV-2 eradication time (follow-up 24 weeks).